Skip to main content
. 2017 Mar 22;7:238. doi: 10.1038/s41598-017-00316-3

Figure 5.

Figure 5

Forest plots depicting the effect of Alirocumab for subgroup analysis after grouping by methods of treatment. (a) on LDL-C; (b) on HDL; (c) on TC; (d) on TG; (e) on Apo-B; (f) on Lp(a); (g) on Apo-A1.